Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,048 | 28,284 | 41,739 | 90,942 | 249,073 |
| Marketable Securities | 154,238 | 150,904 | 186,150 | 131,882 | 43,159 |
| Receivables | 300 | 121 | N/A | N/A | N/A |
| TOTAL | $203,009 | $185,156 | $233,855 | $228,164 | $296,884 |
| Non-Current Assets | |||||
| PPE Net | 2,460 | 2,659 | 2,559 | 1,967 | 1,981 |
| Investments And Advances | 45,554 | 81,974 | 50,997 | 77,082 | 11,102 |
| Other Non-Current Assets | 17,280 | 12,367 | 9,897 | 3,463 | 2,092 |
| TOTAL | $65,294 | $97,000 | $63,453 | $82,512 | $15,175 |
| Total Assets | $268,303 | $282,156 | $297,308 | $310,676 | $312,059 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,803 | 685 | 1,018 | 3,399 | 956 |
| Accrued Expenses | 6,146 | 5,682 | 4,190 | 4,659 | 4,353 |
| TOTAL | $13,563 | $9,365 | $7,618 | $11,857 | $5,309 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,287 | 1,733 | 1,000 | 1,000 | N/A |
| Other Non-Current Liabilities | 6,078 | 6,373 | 6,619 | 295 | 293 |
| TOTAL | $8,245 | $9,240 | $10,619 | $4,306 | $296 |
| Total Liabilities | $21,808 | $18,605 | $18,237 | $16,163 | $5,605 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,066 | 43,020 | 42,457 | 41,845 | 41,726 |
| Retained earnings | -177,014 | -157,585 | -130,732 | -113,203 | -99,818 |
| Other shareholders' equity | 63 | 337 | 283 | 44 | -1 |
| TOTAL | $246,495 | $263,551 | $279,071 | $294,513 | $306,454 |
| Total Liabilities And Equity | $268,303 | $282,156 | $297,308 | $310,676 | $312,059 |